Clinical Trial

Which Tools Better Predict Fall Risk in Parkinson's Disease: A Comparative Study of Objective, Self-Reported, and Functional Balance Assessment

Completed
View on ClinicalTrials.gov →
Summary
Introduction: Falls are common in Parkinson's disease (PD), affecting 30-90% of patients annually, with more than half experiencing recurrent falls. Identifying balance assessment tools that are both practical and predictive of fall risk is therefore essential. This study aimed to investigate the relationship between fall frequency and three balance assessment tools: the Biodex Balance System (objective), the Falls Efficacy Scale-International (FES-I) (self-reported), and the Mini-Balance Evaluation Systems Test (Mini-BESTest) (functional). Methods: Patients with PD at Hoehn and Yahr stages 1-3 will be included in the study. Fall data will be collected using a fall diary, while objective balance will be assessed with the Biodex Balance System, functional performance will be evaluated with the Mini-BESTest, and self-reported balance confidence will be measured with the FES-I.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-08-28.
Status change: Recruiting → Completed 2026-07-08
Trial Details
NCT Number NCT07148700
Lead Sponsor Bezmialem Vakif University
Conditions PARKINSON DISEASE (Disorder), Parkinson, Parkinson s Disease, Parkinson Disease, Parkinson Disease (PD)
Enrollment 40 participants
Start Date 2025-05-01
Primary Completion 2025-08-25 (estimated)
Study Completion 2025-08-30 (estimated)
Updated on ClinicalTrials.gov 2026-07-09